# Dr. Reddy'S Laboratories (RDY) — Analyst Forecast

RDY · NYSE · Stock

Canonical page: https://www.lighthorse.io/tickers/rdy/forecast

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Sep 29, 2026 | Citigroup | Upgraded | Sell → Buy | $1,450.00 |
| Jun 5, 2025 | HSBC | Upgraded | Hold → Buy | $16.90 |
| Nov 6, 2024 | Barclays | Maintained | Overweight | $17.00 |
| Jul 30, 2024 | Barclays | Maintained | Overweight | $87.00 |
| May 8, 2024 | Barclays | Maintained | Overweight | $81.00 |
| Jan 29, 2024 | Barclays | Maintained | Overweight | $80.00 |
| Jun 1, 2023 | Barclays | Maintained | Overweight | $70.00 |

## Frequently Asked Questions

### What is the latest analyst rating on RDY?

On Sep 29, 2026, Citigroup upgraded Dr. Reddy'S Laboratories to Buy with a price target of $1,450.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).